Long-Term Survival With Allogeneic Stem Cell Transplant and Donor Lymphocyte Infusion Following Salvage Therapy with Anti-CD52 Monoclonal Antibody (Campath) in a Patient with α/β Hepatosplenic T-Cell Non-Hodgkin's Lymphoma

Asher Chanan-Khan Department of Medicine, Roswell Park Cancer Institute, Elm & Carlton Street, Buffalo, NY, 14263, USACorrespondence[email protected]

Tariq Islam Department of Surgery, Roswell Park Cancer Institute, Elm & Carlton Street, Buffalo, NY, 14263, USA

Arif Alam Department of Pathology, Roswell Park Cancer Institute, Elm & Carlton Street, Buffalo, NY, 14263, USA

Kena C Miller Department of Medicine, Roswell Park Cancer Institute, Elm & Carlton Street, Buffalo, NY, 14263, USA

John Gibbs Department of Surgery, Roswell Park Cancer Institute, Elm & Carlton Street, Buffalo, NY, 14263, USA

Maurice Barcos Department of Pathology, Roswell Park Cancer Institute, Elm & Carlton Street, Buffalo, NY, 14263, USA

Myron S Czuczman Department of Medicine, Roswell Park Cancer Institute, Elm & Carlton Street, Buffalo, NY, 14263, USA

Pamela Paplham Department of Surgery, Roswell Park Cancer Institute, Elm & Carlton Street, Buffalo, NY, 14263, USA

Theresa Hahn Department of Pathology, Roswell Park Cancer Institute, Elm & Carlton Street, Buffalo, NY, 14263, USA

Philip McCarthy Department of Medicine, Roswell Park Cancer Institute, Elm & Carlton Street, Buffalo, NY, 14263, USA

Related research